Donald Trump's executive order aims to drastically cut US prescription drug prices, aligning them with the lowest prices in ...

Regulatory reform is rising on global policy agendas. Yet while this regulatory reform agenda promises relief for firms, it ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

The difference comes from the sourcing of raw materials and the functioning – and even nature – of supply chains. Because the ...

Nordic Capital and Riverside see investment opportunities in interoperability, automation and compliance software for global ...

Empower Pharmacy markets itself as a well-meaning rival to Big Pharma - one that seeks to democratize medicine by making ...

Pakistan Single Window (PSW) has integrated key export-related services of the Drug Regulatory Authority of Pakistan (DRAP) into its digital platform, ...

The legalization of adult-use cannabis across numerous U.S. states was driven by more than economic or regulatory motivations ...

Drug companies and specialty distributors navigate challenges like profitability, supply chain volatility, regulatory complexities, and market pressures to build successful partnerships, said Natalie ...

Alleging that medicines are increasingly being routed into Karnataka from external markets through unauthorised distribution ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...